CorMedix (CRMD) EBT Margin Growth (3y) (2016 - 2025)

CorMedix (CRMD) EBT Margin Growth (3y) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,237.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -408.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 2.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.77 Mn
Sep 30, 2025 10.06 Mn
Jun 30, 2025 3.86 Mn
Mar 31, 2025 10.69 Mn
Dec 31, 2024 1.39 Mn
Sep 30, 2024 2.25 Mn
Jun 30, 2024 7.01 Mn
Dec 31, 2022 -15.92 Mn
Sep 30, 2022 -9.17 Mn
Jun 30, 2022 -2.22 Mn
Mar 31, 2022 -10.26 Mn
Dec 31, 2021 -2.19 Mn
Sep 30, 2021 -1.98 Mn
Jun 30, 2021 4.15 Mn
Mar 31, 2021 2.43 Mn
Dec 31, 2020 15,456.00
Sep 30, 2020 596,596.00
Jun 30, 2020 -4.93 Mn
Mar 31, 2020 1.31 Mn
Dec 31, 2019 10.97 Mn